Lexaria Bioscience (LEXX) Stock: Buy, Sell, or Hold?
LEXX - Lexaria Bioscience Corp. Common Stock
$3.08
0.09 (3.01%)
â˛
5d:
+7.69%
30d:
-8.61%
90d:
+490.6%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 25, 2026
29d
Get Alerted When LEXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LEXX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LEXX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LEXX is currently trading at $3.08, which is considered fair relative to its 30-day fair value range of $2.86 to $3.32.
Technical Outlook: Technically, LEXX is in a uptrend. Immediate support is located at $2.43, while resistance sits at $3.62. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $82.50 (+2578.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEXX is in a uptrend. Immediate support is located at $2.43, while resistance sits at $3.62. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $82.50 (+2578.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.86 -
$3.32
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 2578.6% below Wall St target ($82.50)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.86 -
$3.32
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.43
Resistance Level
$3.62
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.66
Wall Street Target
$82.50
(+2578.6%)
Revenue Growth (YoY)
-88.5%
Share & Embed Analysis
Last updated: October 25, 2026 10:29 PM ET
Data refreshes hourly during market hours. Next update: 11:29 PM
Data refreshes hourly during market hours. Next update: 11:29 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEXX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
23 analysts |
$109 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$196 | 53 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$685 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 59 HOLD |
